A survival guide to early T cell development

Immunologic Research

Volumn 34, Issue 2, 2006, Pages 117-132

  Ciofani, Maria ^a   Zuniga Pflucker, Juan Carlos ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Apoptosis; Cytokines; Metabolism; Notch receptor; Pre TCR; Survival; T cell development; Thymus

Indexed keywords

CYTOKINE; INTEGRIN; INTERLEUKIN 7; INTERLEUKIN 7 RECEPTOR; NOTCH1 RECEPTOR; PROTEIN P53; T LYMPHOCYTE RECEPTOR; VASCULAR CELL ADHESION MOLECULE 1;

APOPTOSIS; CELL DEATH; CELL DIFFERENTIATION; CELL GROWTH; CELL MATURATION; CELL METABOLISM; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; THYMOCYTE;

ANIMALS; CELL DIFFERENTIATION; CELL SURVIVAL; CYTOKINES; GENES, T-CELL RECEPTOR BETA; HUMANS; INTEGRINS; RECEPTORS, NOTCH; T-LYMPHOCYTES;

EID: 33745698041     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1385/IR:34:2:117     Document Type: Review

References (141)

1. Raff MC: Social controls on cell survival and cell death. Nature 1992;356:397-400.
2. Schmitt TM, Zúñiga-Pflücker JC: Thymus-derived signals regulate early T-cell development. Crit Rev Immunol 2005;25:141-159.
3. Dudley EC, Petrie HT, Shah LM, Owen MJ. Hayday AC: T cell receptor beta chain gene rearrangement and selection during thymocyte development in adult mice. Immunity 1994;1:83-93.
4. von Boehmer H, Aifantis I, Feinberg J, et al: Pleiotropic changes controlled by the pre-T-cell receptor. Curr Opin Immunol 1999;11:135-142.
5. Starr TK, Jameson SC, Hogquist KA: Positive and negative selection of T cells. Annu Rev Immunol 2003;21:139-176.
6. Godfrey DI, Kennedy J, Suda T, Zlotnik A: A developmental pathway involving four phenotypically and functionally distinct subsets of CD3-CD4-CD8-triple-negative adult mouse thymocytes defined by CD44 and CD25 expression. J Immunol 1993;150:4244-4252.
7. Capone M, Hockett RD, Jr, Zlotnik A: Kinetics of T cell receptor beta, gamma, and delta rearrangements during adult thymic development: T cell receptor rearrangements are present in CD44(+)CD25(+) Pro-T thymocytes. Proc Natl Acad Sci USA 1998;95:12522-12527.
8. Godfrey DI, Kennedy J, Mombaerts P, Tonegawa S, Zlotnik A: Onset of TCR-beta gene rearrangement and role of TCR-beta expression during CD3-CD4-CD8-thymocyte differentiation. J Immunol 1994;152:4783-4792.
9. Livak F, Tourigny M, Schatz DG, Petrie HT: Characterization of TCR gene rearrangements during adult murine T cell development. J Immunol 1999;162:2575-2580.
10. Kang J, Coles M, Cado D, Raulet DH: The developmental fate of T cells is critically influenced by TCRgammadelta expression. Immunity 1998;8:427-438.
11. Passoni L, Hoffman ES, Kim S, et al: Intrathymic delta selection events in gammadelta cell development. Immunity 1997;7:83-95.
12. Michie AM, Zúñiga-Pflücker JC: Regulation of thymocyte differentiation: pre-TCR signals and beta-selection. Semin Immunol 2002;14:311-323.
13. Pinkoski MJ, Green DR: Apoptosis in the regulation of immune responses. J Rheumatol Suppl 2005;74:19-25.
14. Mak TW, Yeh WC: Signaling for survival and apoptosis in the immune system. Arthritis Res 2002;4 Suppl 3:S243-252.
15. Zou H, Henzel WJ, Liu X, Lutschg A, Wang X: Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 1997;90:405-413.
16. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X: Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997;91:479-489.
17. Chipuk JE, Green DR: Do inducers of apoptosis trigger caspase-independent cell death? Nat Rev Mol Cell Biol 2005;6:268-275.
18. Marsden VS, Strasser A: Control of apoptosis in the immune system: Bcl-2, BH3-only proteins and more. Annu Rev Immunol 2003;21:71-105.
19. Green DR, Kroemer G: The pathophysiology of mitochondrial cell death. Science 2004;305:626-629.
20. Chen L, Willis SN, Wei A, et al: Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell 2005;17:393-403.
21. Strasser A: The role of BH3-only proteins in the immune system. Nat Rev Immunol 2005;5:189-200.
22. Kuwana T, Bouchier-Hayes L, Chipuk JE, et al: BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly. Mol Cell 2005;17:525-535.
23. Nicholson KM, Anderson NG: The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal 2002;14:381-395.
24. del Peso L, Gonzalez-Garcia M, Page C, Herrera R, Nunez G: Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 1997;278:687-689.
25. Arden KC, Biggs WH, 3rd: Regulation of the FoxO family of transcription factors by phosphatidylinositol-3 kinase-activated signaling. Arch Biochem Biophys 2002;403:292-298.
26. Pekarsky Y, Hallas C, Palamarchuk A, et al: Akt phosphorylates and regulates the orphan nuclear receptor Nur77. Proc Natl Acad Sci USA 2001;98:3690-3694.
27. Kandel ES, Hay N: The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. Exp Cell Res 1999;253:210-229.
28. Vander Heiden MG, Plas DR, Rathmell JC, Fox CJ, Harris MH, Thompson CB: Growth factors can influence cell growth and survival through effects on glucose metabolism. Mol Cell Biol 2001;21:5899-5912.
29. Rathmell JC, Fox CJ, Plas DR, Hammerman PS, Cinalli RM, Thompson CB: Akt-directed glucose metabolism can prevent Bax conformation change and promote growth factor-independent survival. Mol Cell Biol 2003;23:7315-7328.
30. Whetton AD, Bazill GW, Dexter TM: Haemopoietic cell growth factor mediates cell survival via its action on glucose transport. EMBO J 1984;3:409-413.
31. Rathmell JC, Vander Heiden MG, Harris MH, Frauwirth KA, Thompson CB: In the absence of extrinsic signals, nutrient utilization by lymphocytes is insufficient to maintain either cell size or viability. Mol Cell 2000;6:683-692.
32. Edinger AL, Thompson CB: Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake. Mol Biol Cell 2002;13:2276-2288.
33. Plas DR, Thompson CB: Cell metabolism in the regulation of programmed cell death. Trends Endocrinol Metab 2002;13:75-78.
34. Fox CJ, Hammerman PS, Thompson CB: Fuel feeds function: energy metabolism and the T-cell response. Nat Rev Immunol 2005;5:844-852.
35. Khaled AR, Durum SK: Death and Baxes: mechanisms of lymphotrophic cytokines. Immunol Rev 2003;193:48-57.
36. Ogawa M, Matsuzaki Y, Nishikawa S, et al: Expression and function of c-kit in hemopoietic progenitor cells. J Exp Med 1991;174:63-71.
37. Rodewald HR, Kretzschmar K, Swat W, Takeda S: Intrathymically expressed c-kit ligand (stem cell factor) is a major factor driving expansion of very immature thymocytes in vivo. Immunity 1995;3:313-319.
38. Di Santo JP, Rodewald HR: In vivo roles of receptor tyrosine kinases and cytokine receptors in early thymocyte development. Curr Opin Immunol 1998;10:196-207.
39. Sudo T, Nishikawa S, Ohno N, et al: Expression and function of the interleukin 7 receptor in murine lymphocytes. Proc Natl Acad Sci USA 1993;90:9125-9129.
40. Van De Wiele CJ, Marino JH, Murray BW, Vo SS, Whetsell ME, Teague TK: Thymocytes between the beta-selection and positive selection checkpoints are nonresponsive to IL-7 as assessed by STAT-5 phosphorylation. J Immunol 2004;172:4235-4244.
41. Yu Q, Park JH, Doan LL, Erman B, Feigenbaum L, Singer A: Cytokine signal transduction is suppressed in preselection double-positive thymocytes and restored by positive selection. J Exp Med 2006;203:165-175.
42. von Freeden-Jeffry U, Vieira P, Lucian LA, McNeil T, Burdach SE, Murray R: Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J Exp Med 1995;181:1519-1526.
43. Peschon JJ, Morrissey PJ, Grabstein KH, et al: Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J Exp Med 1994;180:1955-1960.
44. Cao X, Shores EW, Hu-Li J, et al: Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. Immunity 1995;2:223-238.
45. Moore TA, von Freeden-Jeffry U, Murray R, Zlotnik A: Inhibition of gamma delta T cell development and early thymocyte maturation in IL-7 -/- mice. J Immunol 1996;157:2366-2373.
46. Maki K, Sunaga S, Komagata Y, et al: Interleukin 7 receptor-deficient mice lack gammadelta T cells. Proc Natl Acad Sci USA 1996;93:7172-7177.
47. Malissen M, Pereira P, Gerber DJ, Malissen B, DiSanto JP: The common cytokine receptor gamma chain controls survival of gamma/delta T cells. J Exp Med 1997;186:1277-1285.
48. Rodewald HR, Ogawa M, Haller C, Waskow C, DiSanto JP: Pro-thymocyte expansion by c-kit and the common cytokine receptor gamma chain is essential for repertoire formation. Immunity 1997;6:265-272.
49. Akashi K, Kondo M, von Freeden-Jeffry U, Murray R, Weissman IL: Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice. Cell 1997;89:1033-1041.
50. von Freeden-Jeffry U, Solvason N, Howard M, Murray R: The earliest T lineage-committed cells depend on IL-7 for Bcl-2 expression and normal cell cycle progression. Immunity 1997;7:147-154.
51. Kim K, Lee CK, Sayers TJ, Muegge K, Durum SK: The trophic action of IL-7 on pro-T cells: inhibition of apoptosis of pro-T1, -T2, and -T3 cells correlates with Bcl-2 and Bax levels and is independent of Fas and p53 pathways. J Immunol 1998;160:5735-5741.
52. Maraskovsky E, O'Reilly LA, Teepe M, Corcoran LM, Peschon JJ, Strasser A: Bcl-2 can rescue T lymphocyte development in interleukin-7 receptor-deficient mice but not in mutant rag-1-/- mice. Cell 1997;89:1011-1019.
53. Kondo M, Akashi K, Domen J, Sugamura K, Weissman IL: Bcl-2 rescues T lymphopoiesis, but not B or NK cell development, in common gamma chain-deficient mice. Immunity 1997;7:155-162.
54. Rodewald HR, Waskow C, Haller C: Essential requirement for c-kit and common gamma chain in thymocyte development cannot be overruled by enforced expression of Bcl-2. J Exp Med 2001;193:1431-1437.
55. Nakajima H, Leonard WJ: Role of Bcl-2 in alpha beta T cell development in mice deficient in the common cytokine receptor gamma-chain: the requirement for Bcl-2 differs depending on the TCR/MHC affinity. J Immunol 1999;162:782-790.
56. Maki K, Sunaga S, Ikuta K: The V-J recombination of T cell receptor-gamma genes is blocked in interleukin-7 receptor-deficient mice. J Exp Med 1996;184:2423-2427.
57. Durum SK, Candeias S, Nakajima H, et al: Interleukin 7 receptor control of T cell receptor gamma gene rearrangement: role of receptor-associated chains and locus accessibility. J Exp Med 1998;188:2233-2241.
58. Veis DJ, Sorenson CM, Shutter JR, Korsmeyer SJ: Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 1993;75:229-240.
59. Matsuzaki Y, Nakayama K, Nakayama K, et al: Role of bcl-2 in the development of lymphoid cells from the hematopoietic stem cell. Blood 1997;89:853-862.
60. Nakayama K, Nakayama K, Negishi I, Kuida K, Sawa H, Loh DY: Targeted disruption of Bcl-2 alpha beta in mice: occurrence of gray hair, polycystic kidney disease, and lymphocytopenia. Proc Natl Acad Sci USA 1994;91:3700-3704.
61. Yang T, Buchan HL, Townsend KJ, Craig RW: MCL-1, a member of the BLC-2 family, is induced rapidly in response to signals for cell differentiation or death, but not to signals for cell proliferation. J Cell Physiol 1996;166:523-536.
62. Opferman JT, Letai A, Beard C, Sorcinelli MD, Ong CC, Korsmeyer SJ: Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1. Nature 2003;426:671-676.
63. Opferman JT, Iwasaki H, Ong CC, et al: Obligate role of anti-apoptotic MCL-1 in the survival of hematopoietic stem cells. Science 2005;307:1101-1104.
64. Khaled AR, Li WQ, Huang J, et al: Bax deficiency partially corrects interleukin-7 receptor alpha deficiency. Immunity 2002;17:561-573.
65. Li WQ, Jiang Q, Khaled AR, Keller JR, Durum SK: Interleukin-7 inactivates the pro-apoptotic protein Bad promoting T cell survival. J Biol Chem 2004;279:29160-29166.
66. Khaled AR, Kim K, Hofmeister R, Muegge K, Dumm SK: Withdrawal of IL-7 induces Bax translocation from cytosol to mitochondria through a rise in intracellular pH. Proc Natl Acad Sci USA 1999;96:14476-14481.
67. Wen R, Wang D, McKay C, et al: Jak3 selectively regulates Bax and Bcl-2 expression to promote T-cell development. Mol Cell Biol 2001;21:678-689.
68. Pellegrini M, Bouillet P, Robati M, Belz GT, Davey GM, Strasser A: Loss of Bim increases T cell production and function in interleukin 7 receptor-deficient mice. J Exp Med 2004;200:1189-1195.
69. Pallard C, Stegmann AP, van Kleffens T, Smart F, Venkitaraman A, Spits H: Distinct roles of the phosphatidylinositol 3-kinase and STAT5 pathways in IL-7-mediated development of human thymocyte precursors. Immunity 1999;10:525-535.
70. Barata JT, Silva A, Brandao JG, Nadler LM, Cardoso AA, Boussiotis VA: Activation of PI3K is indispensable for interleukin 7-mediated viability, proliferation, glucose use, and growth of T cell acute lymphoblastic leukemia cells. J Exp Med 2004;200:659-669.
71. Sade H, Sarin A: IL-7 inhibits dexamethasone-induced apoptosis via Akt/PKB in mature, peripheral T cells. Eur J Immunol 2003;33:913-919.
72. Hagenbeek TJ, Naspetti M, Malergue F, et al: The loss of PTEN allows TCR alphabeta lineage thymocytes to bypass IL-7 and Pre-TCR-mediated signaling. J Exp Med 2004;200:883-894.
73. Rathmell JC, Farkash EA, Gao W, Thompson CB: IL-7 enhances the survival and maintains the size of naive T cells. J Immunol 2001;167:6869-6876.
74. Yu Q, Erman B, Bhandoola A, Sharrow SO, Singer A: In vitro evidence that cytokine receptor signals are required for differentiation of double positive thymocytes into functionally mature CD8+ T cells. J Exp Med 2003;197:475-487.
75. Cho H, Mu J, Kim JK, et al: Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 2001;292:1728-1731.
76. Cho H, Thorvaldsen JL, Chu Q, Feng F, Birnbaum MJ: Aktl/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J Biol Chem 2001;276:38349-38352.
77. Swat W, Montgrain V, Doggett TA, et al: The essential role of PI3K{delta} and PI3K{gamma} in thymocyte survival. Blood 2006;107:2415-2422.
78. Webb LM, Vigorito E, Wymann MP, Hirsch E, Turner M: Cutting edge: T cell development requires the combined activities of the p110gamma and p110delta catalytic isoforms of phosphatidylinositol 3-kinase. J Immunol 2005;175:2783-2787.
79. Fox CJ, Hammerman PS, Thompson CB: The Pim kinases control rapamycin-resistant T cell survival and activation. J Exp Med 2005;201:259-266.
80. Calo V, Migliavacca M, Bazan V, et al: STAT proteins: from normal control of cellular events to tumorigenesis. J Cell Physiol 2003;197:157-168.
81. Fox CJ, Hammerman PS, Cinalli RM, Master SR, Chodosh LA, Thompson CB: The serine/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor. Genes Dev 2003;17:1841-1854.
82. Yan B, Zemskova M, Holder S, et al: The PIM-2 kinase phosphorylates BAD on serine 112 and reverses BAD-induced cell death. J Biol Chem 2003;278:45358-45367.
83. Mikkers H, Nawijn M, Allen J, et al: Mice deficient for all PIM kinases display reduced body size and impaired responses to hematopoietic growth factors. Mol Cell Biol 2004;24:6104-6115.
84. Jacobs H, Krimpenfort P, Haks M, et al: PIM1 reconstitutes thymus cellularity in interleukin 7- and common gamma chain-mutant mice and permits thymocyte maturation in Rag- but not CD3gamma-deficient mice. J Exp Med 1999;190:1059-1068.
85. Haks MC, Krimpenfort P, van den Brakel JH, Kruisbeek AM: Pre-TCR signaling and inactivation of p53 induces crucial cell survival pathways in pre-T cells. Immunity 1999;11:91-101.
86. Falk I, Nerz G, Haidl I, Krotkova A, Eichmann K: Immature thymocytes that fail to express TCRbeta and/or TCRgamma delta proteins die by apoptotic cell death in the CD44(-)CD25(-) (DN4) subset. Eur J Immunol 2001;31:3308-3317.
87. Mandal M, Borowski C, Palomero T, et al: The BCL2A1 gene as a pre-T cell receptor-induced regulator of thymocyte survival. J Exp Med 2005;201:603-614.
88. Jiang D, Lenardo MJ, Zúñiga-Pflücker JC: p53 prevents maturation to the CD4+CD8+ stage of thymocyte differentiation in the absence of T cell receptor rearrangement. J Exp Med 1996;183:1923-1928.
89. Guidos CJ, Williams CJ, Grandal I, Knowles G, Huang MT, Danska JS: V(D)J recombination activates a p53-dependent DNA damage checkpoint in scid lymphocyte precursors. Genes Dev 1996;10:2038-2054.
90. Schuler M, Green DR: Transcription, apoptosis and p53: catch-22. Trends Genet 2005;21:182-187.
91. Villunger A, Michalak EM, Coultas L, et al: p53- and drag-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science 2003;302:1036-1038.
92. Chipuk JE, Bouchier-Hayes L, Kuwana T, Newmeyer DD, Green DR: PUMA couples the nuclear and cytoplasmic proapoptotic function of p53. Science 2005;309:1732-1735.
93. Newton K, Harris AW, Strasser A: FADD/MORT1 regulates the pre-TCR checkpoint and can function as a tumour suppressor. EMBO J 2000;19:931-941.
94. Wang EC, Thern A, Denzel A, Kitson J, Farrow SN, Owen MJ: DR3 regulates negative selection during thymocyte development. Mol Cell Biol 2001;21:3451-3461.
95. Zhang N, He YW: An essential role for c-FLIP in the efficient development of mature T lymphocytes. J Exp Med 2005;202:395-404.
96. Chau H, Wong V, Chen NJ, et al: Cellular FLICE-inhibitory protein is required for T cell survival and cycling. J Exp Med 2005;202:405-413.
97. Zhang J, Cado D, Chen A, Kabra NH, Winoto A: Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1. Nature 1998;392:296-300.
98. Salmena L, Lemmers B, Hakem A, et al: Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity. Genes Dev 2003;17:883-895.
99. Kabra NH, Kang C, Hsing LC, Zhang J, Winoto A: T cell-specific FADD-deficient mice: FADD is required for early T cell development. Proc Natl Acad Sci USA 2001;98:6307-6312.
100. Voll RE, Jimi E, Phillips PJ, et al: NF-kappa B activation by the pre-T cell receptor serves as a selective survival signal in T lymphocyte development. Immunity 2000;13:677-689.
101. Aifantis I, Gounari F, Scorrano L, Borowski C, von Boehmer H: Constitutive pre-TCR signaling promotes differentiation through Ca2+ mobihzation and activation of NF-kappaB and NFAT. Nat Immunol 2001;2:403-409.
102. Lucas PC, McAllister-Lucas LM, Nunez G: NF-kappaB signaling in lymphocytes: a new cast of characters. J Cell Sci 2004;117:31-39.
103. Michie AM, Soh JW, Hawley RG, Weinstein IB, Zúñiga- Pflücker JC: Allelic exclusion and differentiation by protein kinase C-mediated signals in immature thymocytes. Proc Natl Acad Sci USA 2001;98:609-614.
104. Ciofani M, Schmitt TM, Ciofani A, et al: Obligatory role for cooperative signaling by pre-TCR and Notch during thymocyte differentiation. J Immunol 2004;172:5230-5239.
105. Sun Z, Arendt CW, Ellmeier W, et al: PKC-theta is required for TCR-induced NF-kappaB activation in mature but not immature T lymphocytes. Nature 2000;404:402-407.
106. Motoyama N, Wang F, Roth KA, et al: Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science 1995;267:1506-1510.
107. Strasser A, Harris AW, Corcoran LM, Cory S: Bcl-2 expression promotes B- but not T-lymphoid development in scid mice. Nature 1994;368:457-460.
108. Chao DT, Korsmeyer SJ: BCL-XL-regulated apoptosis in T cell development. Int Immunol 1997;9:1375-1384.
109. Gonzalez J, Orlofsky A, Prystowsky MB: A1 is a growth-permissive antiapoptotic factor mediating postactivation survival in T cells. Blood 2003;101:2679-2685.
110. Schmitt TM, Ciofani M, Petrie HT, Zúñiga-Pflücker JC: Maintenance of T cell specification and differentiation requires recurrent notch receptor-ligand interactions. J Exp Med 2004;200:469-479.
111. Radtke F, Wilson A, Mancini SJ, MacDonald HR: Notch regulation of lymphocyte development and function. Nat Immunol 2004;5:247-253.
112. Maillard I, Fang T, Pear WS: Regulation of lymphoid development, differentiation, and function by the Notch pathway. Annu Rev Immunol 2005;23:945-974.
113. Wolfer A, Wilson A, Nemir M, MacDonald HR, Radtke F: Inactivation of Notchl impairs VDJbeta rearrangement and allows pre-TCR-independent survival of early alpha beta Lineage Thymocytes. Immunity 2002;16:869-879.
114. Tanigaki K, Tsuji M, Yamamoto N, et al: Regulation of alphabeta/gammadelta T cell lineage commitment and peripheral T cell responses by Notch/RBP-J signaling. Immunity 2004;20:611-622.
115. Schmitt TM, Zúñiga-Pflücker JC: Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro. Immunity 2002;17:749-756.
116. Zúñiga-Pflücker JC: T-cell development made simple. Nat Rev Immunol 2004;4:67-72.
117. Ciofani M, Zúñiga-Pflücker JC: Notch promotes survival of pre-T cells at the beta-selection checkpoint by regulating cellular metabolism. Nat Immunol 2005;6:881-888.
118. Deftos ML, He YW, Ojala EW, Bevan MJ: Correlating notch signaling with thymocyte maturation. Immunity 1998;9:777-786.
119. Jehn BM, Bielke W, Pear WS, Osborne BA: Cutting edge: protective effects of notch-1 on TCR-induced apoptosis. J Immunol 1999;162:635-638.
120. Sade H, Krishna S, Sarin A: The anti-apoptotic effect of Notch-1 requires p561ck-dependent, Akt/PKB-mediated signaling in T cells. J Biol Chem 2004;279:2937-2944.
121. Bellavia D, Campese AF, Alesse E, et al: Constitutive activation of NF-kappaB and T-cell leukemia/lymphoma in Notch3 transgenic mice. EMBO J 2000;19:3337-3348.
122. Talora C, Campese AF, Bellavia D, et al: Pre-TCR-triggered ERK signalling-dependent downregulation of E2A activity in Notch3-induced T-cell lymphoma. EMBO Rep 2003;4:1067-1072.
123. Huang EY, Gallegos AM, Richards SM, Lehar SM, Bevan MJ: Surface expression of Notch1 on thymocytes: correlation with the double-negative to double-positive transition. J Immunol 2003;171:2296-2304.
124. Allman D, Sambandam A, Kim S, et al: Thymopoiesis independent of common lymphoid progenitors. Nat Immunol 2003;4:168-174.
125. Porritt HE, Rumfelt LL, Tabrizifard S, Schmitt TM, Zúñiga- Pflücker JC, Petrie HT: Heterogeneity among DN1 prothymocytes reveals multiple progenitors with different capacities to generate T cell and non-T cell lineages. Immunity 2004;20:735-745.
126. Lind EF, Prockop SE, Porritt HE, Petrie HT: Mapping precursor movement through the postnatal thymus reveals specific microenvironments supporting defined stages of early lymphoid development. J Exp Med 2001;194:127-134.
127. Porritt HE, Gordon K, Petrie HT: Kinetics of state differentiation and mapping of intrathymic-signaling environments by stem cell transplantation in nonirradiated mice. J Exp Med 2003;198:957-962.
128. Petrie HT: Cell migration and the control of post-natal T-cell lymphopoiesis in the thymus. Nat Rev Immunol 2003;3:859-866.
129. Prockop SE, Palencia S, Ryan CM, Gordon K, Gray D, Petrie HT: Stromal cells provide the matrix for migration of early lymphoid progenitors through the thymic cortex. J Immunol 2002;169:4354-4361.
130. Ara T, Itoi M, Kawabata K, et al: A role of CXC chemokine ligand 12/stromal cell-derived factor-1/pre-B cell growth stimulating factor and its receptor CXCR4 in fetal and adult T cell development in vivo. J Immunol 2003;170:4649-4655.
131. Plotkin J, Prockop SE, Lepique A, Petrie HT: Critical role for CXCR4 signaling in progenitor localization and T cell differentiation in the postnatal thymus. J Immunol 2003;171:4521-4527.
132. Misslitz A, Pabst O, Hintzen G, et al: Thymic T cell development and progenitor localization depend on CCR7. J Exp Med 2004;200:481-491.
133. Vielkind S, Gallagher-Gambarelli M, Gomez M, Hinton HJ, Cantrell DA: Integrin regulation by RhoA in thymocytes. J Immunol 2005;175:350-357.
134. Galandrini R, Henning SW, Cantrell DA: Different functions of the GTPase Rho in prothymocytes and late pre-T cells. Immunity 1997;7:163-174.
135. Henning SW, Galandrini R, Hall A, Cantrell DA: The GTPase Rho has a critical regulatory role in thymus development. EMBO J 1997;16:2397-2407.
136. Stupack DG, Cheresh DA: Get a ligand, get a life: integrins, signaling and cell survival. J Cell Sci 2002;115:3729-3738.
137. Youn BS, Yu KY, Oh J, Lee J, Lee TH, Broxmeyer HE: Role of the CC chemokine receptor 9/TECK interaction in apoptosis. Apoptosis 2002;7:271-276.
138. Prockop SE, Petrie HT: Regulation of thymus size by competition for stromal niches among early T cell progenitors. J Immunol 2004;173:1604-1611.
139. Zamisch M, Moore-Scott B, Su DM, Lucas PJ, Manley N, Richie ER: Ontogeny and regulation of IL-7-expressing thymic epithelial cells. J Immunol 2005;174:60-67.
140. Petrie HT, Tourigny M, Burtram DB, Livak F: Precursor thymocyte proliferation and differentiation are controlled by signals unrelated to the pre-TCR. J Immunol 2000;165:3094-3098.
141. Yamasaki S, Ishikawa E, Sakuma M, et al: Mechanistic basis of pre-T cell receptor-mediated autonomous signaling critical for thymocyte development. Nat Immunol 2006;7:67-75.